Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
351 participants
INTERVENTIONAL
2010-07-31
2012-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Does Occlusive Hydrocolloid Silver-containing Wound Dressing After Sternotomy Reduce Surgical Side Infection After Cardiac Surgery?
NCT06508879
Mediastinitis and Staphylococcus Aureus
NCT03262558
Management Practices and the Risk of Infection Following Cardiac Surgery
NCT01089712
Delayed Primary Versus Late Secondary Wound Closure in Sternum Infections
NCT01473979
Dysesthesia Study After Sternotomy
NCT00408044
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Dry Sterile Dressing
Subjects in this study arm received a dry sterile dressing (Primapore®, Smith \& Nephew), a one-piece, peel-and-stick, non-transparent dressing. This dressing is the standard of care at the study facility for this population and was left in place for either 24 to 48 hours.
Dry Sterile Dressing
Described in Arm Description.
Metallic Silver Dressing
Subjects in this arm received a metallic silver dressing (Acticoat Post-Op®, Smith \& Nephew), a one-piece, peel-and-stick and non-transparent dressing. This dressing is an absorbent postoperative dressing consisting of a nanocrystalline silver-coated polyurethane layer, a white polyurethane foam and an adhesive coated waterproof polyurethane film layer. Acticoat Post-Op may be left in place over a wound for up to 7 days. The manufacturers note that the product should not be used in patients with known silver allergies and that it may cause transient discoloration of the skin.
Metallic Silver Dressing
Described in Arm Description.
Ionic Silver Dressing
Subjects in this arm received an ionic silver dressing (Dermanet Ag®, DeRoyal), a semi-transparent dressing that includes silver, alginate, and maltodextrin. The dressing was cut to fit the incision and then covered with a transparent dressing (Transseal®, DeRoyal). This dressing should not be used on patients with known sensitivity to alginates (a seaweed based component).
Ionic Silver Dressing
Described in Arm Description.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Dry Sterile Dressing
Described in Arm Description.
Metallic Silver Dressing
Described in Arm Description.
Ionic Silver Dressing
Described in Arm Description.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Having surgery at the study setting
* English-speaking
* Able to understand and give consent
* Had the approval of their cardiothoracic surgeon to participate
* Had no known sensitivity to silver
* Had no known sensitivity to alginates
Exclusion Criteria
* Known sensitivity to alginates
21 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
DeRoyal Industries, Inc.
INDUSTRY
Smith & Nephew, Inc.
INDUSTRY
Carilion Clinic
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Cathy D. Jennings, DNP
Role: PRINCIPAL_INVESTIGATOR
Carilion Clinic
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Carilion Roanoke Memorial Hospital
Roanoke, Virginia, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CC-2014-1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.